Whitefort Capital Management’s Trinity Biotech TRIB Stock Holding History

Whitefort Capital Management’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-81,902	Closed	-$53.2K	–	20
2025 Q2	$53.2K	Hold	81,902	–	–	0.02%	18
2025 Q1	$46.7K	Hold	81,902	–	–	0.02%	15
2024 Q4	$72.1K	Hold	81,902	–	–	0.03%	17
2024 Q3	$90.1K	Hold	81,902	–	–	0.04%	17
2024 Q2	$174K	Hold	81,902	–	–	0.11%	21
2024 Q1	$167K	Sell	81,902 -1	-0%	-$2	0.1%	17
2023 Q4	$176K	Hold	81,903	–	–	0.11%	19
2023 Q3	$301K	Hold	81,903	–	–	0.16%	17
2023 Q2	$389K	Hold	81,903	–	–	0.37%	12
2023 Q1	$385K	Hold	81,903	–	–	0.36%	13
2022 Q4	$405K	Hold	81,903	–	–	0.32%	15
2022 Q3	$439K	Hold	81,903	–	–	0.49%	12
2022 Q2	$502K	Hold	81,903	–	–	0.63%	11
2022 Q1	$434K	Buy	81,903 +74,889	+1,068%	+$431K	0.41%	21
2021 Q4	$50K	Buy	+7,014	New	+$66.3K	0.04%	38

Other funds holding TRIB

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

MAWA

Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

BCM

Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return

Whitefort Capital Management's TRIB Position: Q3 2025 in Review

Whitefort Capital Management sold out of Trinity Biotech (TRIB) in Q3 2025, closing a stake of 81,902 shares — an estimated $53.2K sold.

Whitefort Capital Management first reported a position in TRIB in Q4 2021 and held it in 15 quarters. The position peaked at $502K in Q2 2022. 28 funds tracked by Wall St. Rank hold TRIB as of Q3 2025.

Whitefort Capital Management reported no remaining Trinity Biotech position as of Q3 2025 after selling out during the quarter.
Whitefort Capital Management sold 81,902 Trinity Biotech shares in Q3 2025, an estimated $53.2K.
Whitefort Capital Management first reported a position in Trinity Biotech in Q4 2021 and held it in 15 quarters.
Whitefort Capital Management's Trinity Biotech position peaked at $502K in Q2 2022.
28 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2025.

Based on Whitefort Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.